CEACAM5 ANTIBODY-DRUG CONJUGATE FORMULATION

Provided are stabilized formulations of the human carcinoembryonic antigen-related cell adhesion molecule 5 (hCEACAM5)-targeted antibody-drug conjugate huMAb2-3-SPDB-DM4, as well as methods for making and using same. Se proporcionan formulaciones estabilizadas del conjugado anticuerpo-fármaco huMAb2...

Full description

Saved in:
Bibliographic Details
Main Authors LEMAN Marie, AUTHELIN Jean- René, HUILLE Sylvain, MANACHE-ALBERICI Lucie, BENSAID Fethi, BONESTEBE Audrey
Format Patent
LanguageEnglish
Spanish
Published 22.05.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Provided are stabilized formulations of the human carcinoembryonic antigen-related cell adhesion molecule 5 (hCEACAM5)-targeted antibody-drug conjugate huMAb2-3-SPDB-DM4, as well as methods for making and using same. Se proporcionan formulaciones estabilizadas del conjugado anticuerpo-fármaco huMAb2-3-SPDB-DM4 dirigido a la molécula de adhesión celular 5 relacionada con el antígeno carcinoembrionario humano (hCEACAM5), así como métodos para fabricarlas y utilizarlas.
Bibliography:Application Number: MX20230005345